Collectively, our results illustrate a novel FAK-TAK1-NFκB signaling axis in LPS-induced inflammation and ALI, and support FAK as a potential target for the treatment of ALI. This evidence concerns the gene MAP3K7 and acute respiratory distress syndrome.